Dolat Capital Broker Research reports

We have upward revised our FY21E and FY23E EPS estimates at Rs 9.5 (+13%) and Rs 9.8 (+0.8%) and introduced FY23E EPS estimates at Rs10.8. We value the stock at 48x FY23E EPS to arrive at a TP of Rs 520....

Astral Poly Technik (ASTRA) Q2FY21 numbers were above our estimates on revenue front and profitability front. Volume growth of 2.2% YoY and 62.4% QoQ in pipe segment as end markets opened up and company had inventory ready and robust distribution network. Pipes business showed a positive growth YoY from Sep'20 onwards. Adhesive segment from the month of July showed a positive growth after a subdued previous quarter. Margins on a full year showed growth as structural changes of eliminating stockists was undertaken....

Alkem reported an in-line 2Q driven by exports and speedy recovery in India. Despite an acute heavy portfolio, India formulations were flattish YoY, up 35% QoQ exhibiting a sharp recovery aided by double digit growth in trade generics. US ($84mn) was strong with 12% CC growth backed by new launches and market share gains. As marketing and promotional activities resume slowly in India (~70%), EBITDA margins came 120bps lower sequentially at 25.4%. However, with promotional activities resuming normalcy we expect 2H to report margins of 15-16%,...

KEI saw revenues in line with estimates but EBIDTA and PAT came in better then estimates (Exhibit 1) led by gross margin expansion of 141bps. The pending order book was Rs26.6bn at the end of H1FY21, compared to Rs29.5bn at the end of Q1, a conscious decline in order...

Pidilite's Q2FY21 results were ahead of our estimate as the improvement in business conditions was better than our anticipation. Consumer Bazaar segment has witnessed strong recovery with +9% growth (55% decline in Q1FY21). Though B2B reported 13% YoY...

Q2 was an operationally good quarter for Concor with revenues in line and EBIDTA and PAT better than estimates (Refer Exhibit 1). Q2 revenues were at Rs15Bn down 13% YoY / up 26% QoQ led -10%/-2% volume/realization decline. EXIM/Domestic Revenue mix stood at 90:10% vs 94:6% YoY/ 84:16% QoQ. EBITDA margin came at 20.8%, sequentially better than that reported in Q1. The company has also...

Minda Corp posted weak margin performance in 2QFY21. Revenue grew 17% YoY while EBITDA remain flat dragged by contraction in gross margin. EBITDA margin stood at 10% (-187bps YoY) led by weak margin in both Mechatronics and Wiring harness segment. Net profit de-grew...

Emami's Q2FY21 results came ahead of our estimates. Domestic business jumped 13%, while IB posted 11% revenue growth in Q2. Ex-winter products (88% contri) reported 28% growth was encouraging performance. Kesh King and Pain management range recorded highest ever quarterly sales during the quarter....

JKLC reported results above estimates on all fronts. JKLC posted 11.7%/ 25.6%/ 75.4% YoY growth in revenue/ EBITDA/ APAT to Rs10.4 bn/ Rs1.9 bn/ Rs806 mn in Q2FY21 led by 15.8% YoY...

We expect 10.2%/ 12.6%/ 16.9% revenue/ EBITDA/ APAT CAGR over FY20-23E led by -4.1%/ 17.7%/ 16.0% volume growth and 1.5%/ 0.5%/ 1.0% cement realization growth in FY21E/ FY22E/ FY23E. We increase our revenue/ EBITDA estimates by 9.0%/ 15.0% for FY21E considering H1FY21 results. Accordingly, we increase our APAT estimates by 39.4% for FY21E. We broadly maintain FY22E and introduce FY23E. We factor 3.9mtpa Mukutban (Maharashtra) expansion to commence by end of Sept'21 (in line with management...